PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma.

about

PD-L1 Expression On tumor Cells Was Associated With Unfavorable Prognosis In Esophageal Squamous Cell Carcinoma.

Item

http://www.wikidata.org/entity/Q55220972

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

PD-L1 Expression On tumor Cell ...... ageal Squamous Cell Carcinoma.

@en

PD-L1 Expression On tumor Cell ...... ageal Squamous Cell Carcinoma.

@nl

type

Item

label

PD-L1 Expression On tumor Cell ...... ageal Squamous Cell Carcinoma.

@en

PD-L1 Expression On tumor Cell ...... ageal Squamous Cell Carcinoma.

@nl

prefLabel

PD-L1 Expression On tumor Cell ...... ageal Squamous Cell Carcinoma.

@en

PD-L1 Expression On tumor Cell ...... ageal Squamous Cell Carcinoma.

@nl

P1476

PD-L1 Expression On tumor Cell ...... hageal Squamous Cell Carcinoma

@en

P2093

Fan Feng

http://www.w3.org/2001/XMLSchema#string

Fei Wang

http://www.w3.org/2001/XMLSchema#string

Gaozan Zheng

http://www.w3.org/2001/XMLSchema#string

Guanghui Xu

http://www.w3.org/2001/XMLSchema#string

Hongwei Zhang

http://www.w3.org/2001/XMLSchema#string

Man Guo

http://www.w3.org/2001/XMLSchema#string

Qiao Wang

http://www.w3.org/2001/XMLSchema#string

Shushang Liu

http://www.w3.org/2001/XMLSchema#string

Xiao Lian

http://www.w3.org/2001/XMLSchema#string

Zhen Liu

http://www.w3.org/2001/XMLSchema#string

P2860

The clinical significance of tumor-infiltrating neutrophils and neutrophil-to-CD8+ lymphocyte ratio in patients with resectable esophageal squamous cell carcinoma

Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.

PD-L1 and Survival in Solid Tumors: A Meta-Analysis

Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy

Pembrolizumab for the treatment of non-small-cell lung cancer

PD-1 blockade induces responses by inhibiting adaptive immune resistance

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

P304

2224-2231

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.24493

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-06-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29937943

http://www.w3.org/2001/XMLSchema#string

P932

6010673

http://www.w3.org/2001/XMLSchema#string